Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Frank Stokes

CFO at Castle Biosciences Inc (CSTL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.5M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 18SEC CSTLCastle Biosciences Inc Sell 24,90835,177 held (−41%) $29.77 $742K +15.6%
Mar 9SEC CSTLCastle Biosciences Inc Sell Plan 6,00160,085 held (−9%) $27.98 $168K +23.0%
Mar 5SEC CSTLCastle Biosciences Inc Sell Plan 5,30054,183 held (−9%) $27.32 $145K +26.0%
Mar 5SEC CSTLCastle Biosciences Inc Sell Plan 1,70052,483 held (−3%) $27.81 $47K +23.8%
Dec 15SEC CSTLCastle Biosciences Inc Sell 4,49650,326 held (−8%) $37.45 $168K -8.1%
Nov 13SEC CSTLCastle Biosciences Inc Sell Plan 5,38843,328 held (−11%) $35.08 $189K -1.9%
  • Sell

    CFO Frank Stokes sold $742K of CSTL at $29.77 — cuts the stake by 41%.

  • Sell

    CFO Frank Stokes sold $168K of CSTL at $27.98 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Frank Stokes sold $145K of CSTL at $27.32 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Frank Stokes sold $47K of CSTL at $27.81 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Frank Stokes sold $189K of CSTL at $35.08 — pre-scheduled 10b5-1 plan sale.